mims-harvard/Madrigal

Madrigal: Multimodal AI predicts clinical outcomes of drug combinations from preclinical data

42
/ 100
Emerging

Madrigal helps drug discovery researchers and pharmacologists predict the clinical outcomes of drug combinations by analyzing multimodal preclinical data. It takes in various types of drug data, such as molecular structures, gene expression profiles, and cell viability assays, and outputs predictions about how two drugs will interact. This is ideal for scientists exploring new drug combinations or evaluating potential drug-drug interactions in early-stage development.

No commits in the last 6 months.

Use this if you need to predict the effects and potential outcomes of combining different drugs based on a variety of preclinical data sources.

Not ideal if you are looking for a simple, off-the-shelf application for immediate clinical decision support without adaptation or a deep understanding of machine learning workflows.

drug-discovery pharmacology preclinical-research drug-development drug-interaction-prediction
Stale 6m No Package No Dependents
Maintenance 2 / 25
Adoption 7 / 25
Maturity 16 / 25
Community 17 / 25

How are scores calculated?

Stars

40

Forks

9

Language

Jupyter Notebook

License

MIT

Last pushed

Jul 31, 2025

Commits (30d)

0

Get this data via API

curl "https://pt-edge.onrender.com/api/v1/quality/llm-tools/mims-harvard/Madrigal"

Open to everyone — 100 requests/day, no key needed. Get a free key for 1,000/day.